Division of Cardiology, Careggi Hospital, Florence, Italy.
J Am Coll Cardiol. 2011 Jul 5;58(2):125-30. doi: 10.1016/j.jacc.2011.02.050.
The aim of the present study was to investigate whether right coronary artery chronic total occlusion (CTO) carries prognostic implications in patients undergoing drug-eluting stent-supported percutaneous coronary intervention (PCI) for unprotected left main disease (ULMD).
No data exist on the prognostic implication of CTO in patients undergoing PCI for ULMD.
Prospective registry of consecutive patients undergoing PCI for ULMD. Patients with ST-segment elevation myocardial infarction were excluded. Primary endpoints were 6-month and long-term cardiac mortality.
From January 2004 to December 2009, 330 patients underwent PCI for ULMD. Of the 330 patients, 78 (24%) had CTO of the right coronary artery, 22 (7%) had CTO of the left anterior descending artery, and 16 (5%) had CTO of the left circumflex artery. Patients with right coronary artery CTO had a higher risk profile compared with patients without right coronary artery CTO. The 6-month mortality rate was 12.8% in patients with right coronary artery CTO, and 3.6% in patients without right coronary artery CTO (p < 0.002), and the 3-year cardiac survival rate was 76.4 ± 6.8% and 89.7 ± 2.7% (p < 0.003), respectively. By multivariable analysis, the only 2 independent predictors of 3-year cardiac mortality were right coronary artery CTO (hazard ratio: 2.15, 95% confidence interval: 1.02 to 4.50; p = 0.043) and EuroSCORE (hazard ratio: 1.03, 95% confidence interval: 1.02 to 1.05; p < 0.001).
Right coronary artery CTO occurs frequently and is a significant predictor of mortality in patients with ULMD undergoing PCI.
本研究旨在探讨右冠状动脉慢性完全闭塞(CTO)是否对行经皮冠状动脉介入治疗(PCI)的无保护左主干病变(ULMD)患者具有预后意义。
目前尚无关于 CTO 对接受 ULMD PCI 治疗的患者的预后影响的数据。
前瞻性连续登记接受 ULMD PCI 的患者。排除 ST 段抬高型心肌梗死患者。主要终点为 6 个月和长期心脏死亡率。
2004 年 1 月至 2009 年 12 月,330 例患者接受 ULMD PCI。330 例患者中,78 例(24%)存在右冠状动脉 CTO,22 例(7%)存在左前降支 CTO,16 例(5%)存在左回旋支 CTO。右冠状动脉 CTO 患者的风险状况高于无右冠状动脉 CTO 患者。右冠状动脉 CTO 患者的 6 个月死亡率为 12.8%,无右冠状动脉 CTO 患者为 3.6%(p < 0.002),3 年心脏生存率分别为 76.4 ± 6.8%和 89.7 ± 2.7%(p < 0.003)。多变量分析显示,3 年心脏死亡率的唯一 2 个独立预测因素是右冠状动脉 CTO(风险比:2.15,95%置信区间:1.02 至 4.50;p = 0.043)和 EuroSCORE(风险比:1.03,95%置信区间:1.02 至 1.05;p < 0.001)。
右冠状动脉 CTO 在接受 PCI 的 ULMD 患者中较为常见,是死亡率的重要预测因素。